文献速递肿瘤 PET/CT

68Ga-PSMA-11 PET/CT诊断前列腺腺癌孤立性双侧肾上腺转移

68Ga-PSMA-11 PET/CT in Isolated Bilateral Adrenal Metastases From Prostate Adenocarcinoma.
PubMed 文献 · Clin Nucl Med · 2022-01-01

一例65岁前列腺腺癌治疗后患者因血清PSA显著升高行68Ga-PSMA-11 PET/CT再分期,显示双侧肾上腺肿块伴高摄取且无其他可疑转移灶,符合孤立性双侧肾上腺转移;接受多西他赛联合雄激素剥夺治疗后PSA逐渐下降,随访MRI示双侧肾上腺肿块显著缩小。

要点

  • 68Ga-PSMA-11 PET/CT可识别前列腺腺癌不典型转移部位如双侧肾上腺。
  • 血清PSA显著升高是再分期行PSMA PET/CT的重要触发因素。
  • 多西他赛联合雄激素剥夺治疗后PSA下降且影像学病灶缩小。

核心结论

  • 68Ga-PSMA-11 PET/CT有助于识别前列腺腺癌的不典型转移(孤立性双侧肾上腺转移)。

研究设计与样本

  • 本文为单例病例报告,描述一例65岁前列腺腺癌治疗后患者的再分期影像与治疗随访。

主要发现

  • 68Ga-PSMA-11 PET/CT显示双侧肾上腺肿块伴高摄取,且无其他可疑转移病灶。
  • 实验室与影像学表现符合前列腺腺癌孤立性双侧肾上腺转移。
  • 患者接受多西他赛化疗联合雄激素剥夺治疗,化疗期间PSA水平逐渐下降。
  • 随访MRI显示双侧肾上腺肿块显著缩小。

关键数值与推荐

  • 患者因血清PSA显著升高而行68Ga-PSMA-11 PET/CT再分期。

临床怎么用

  • 对前列腺腺癌治疗后PSA显著升高患者,可考虑68Ga-PSMA-11 PET/CT评估不典型转移部位。

局限性

  • 本文为单例病例报告,结论的普遍适用性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 65-year-old man with treated prostate adenocarcinoma underwent 68Ga-PSMA-11 PET/CT scan for restaging due to significantly increased serum PSA levels. PET/CT showed bilateral adrenal masses with high 68Ga-PSMA-11 uptake. There was no other lesion suspicious for metastasis. The laboratory and imaging findings were consisted with isolated bilateral adrenal metastases from prostate adenocarcinoma. The patient received docetaxel chemotherapy in combination with androgen deprivation therapy. PSA levels gradually decreased during chemotherapy. Follow-up MRI showed the bilateral adrenal masses significantly decreased in size. This case demonstrates the usefulness of 68Ga-PSMA-11 PET/CT in identifying atypical metastasis from prostate adenocarcinoma.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Zhao Q, Yang B, Dong A, et al. 68Ga-PSMA-11 PET/CT in Isolated Bilateral Adrenal Metastases From Prostate Adenocarcinoma. Clin Nucl Med. 2022. PMID: 34115707. doi:10.1097/RLU.0000000000003759

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。